<DOC>
	<DOCNO>NCT01540955</DOCNO>
	<brief_summary>There 2 million breast cancer survivor US today . Along extend survival , many woman experience short long-term effect treatment , may decrease quality life contribute health problem . Cognitive complaint -- -difficulties memory , concentration , planningâ€”are commonly report adjuvant treatment breast cancer . This study design test efficacy 5 week group-based cognitive rehabilitation intervention improve cognitive complaint test performance , comparison woman receive intervention later time ( wait-list control ) . Women also EEG test perform intervention program see improvement cognitive complaint performance document examine EEG .</brief_summary>
	<brief_title>Cognitive Rehabilitation Group Intervention Breast Cancer Survivors</brief_title>
	<detailed_description>Previous pilot work ( non-randomized , pre-post design ) show intervention effective improve post-intervention cognitive complaint neuropsychological ( NP ) test performance . Because practice effect may influence NP performance , important compare intervention participant woman expose intervention . Thus , randomize control trial compare active intervention control group patient receive intervention delay time point . The primary outcome improvement cognitive complaint NP test performance 2 month completion intervention program . Quantitative EEG ( QEEG ) measurement use secondary exploratory endpoint see may effective biomarker cognitive performance .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>age 2165 year stage I , II , III breast cancer diagnosis within past 18 month 5 year currently disease free , may endocrine therapy evidence need cognitive therapeutic intervention , demonstrate mild great cognitive deficiency objective screen measure read write English able give inform consent willing able attend 5 weekly group session participate pre postevaluation take place UCLA campus evidence uncontrolled depression</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Reduce Cognitive Complaints</keyword>
	<keyword>improve cognitive function</keyword>
	<keyword>post-treatment breast cancer patient</keyword>
</DOC>